# SALT in Adolescents With End-stage Liver Disease

> **NCT06069050** · NA · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 20 (estimated)

## Conditions studied

- End Stage Liver DIsease

## Interventions

- **PROCEDURE:** sequential adolesent left lateral lobe liver transplantation (SALT)

## Key facts

- **NCT ID:** NCT06069050
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069050, "SALT in Adolescents With End-stage Liver Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06069050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*